VNDA
Vanda Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$372.24M
P/E Ratio
—
EPS
$-4.06
Beta
0.65
52W High
$9.94
52W Low
$4.14
50-Day MA
$7.04
200-Day MA
$6.25
Dividend Yield
—
Profit Margin
-110.00%
Forward P/E
103.09
PEG Ratio
2.23
About Vanda Pharmaceuticals Inc
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company is headquartered in Washington, the District of Columbia.
Fundamentals
| Revenue (TTM) | $217.78M |
| Gross Profit (TTM) | $205.10M |
| EBITDA | $-151.98M |
| Operating Margin | -97.10% |
| Return on Equity | -60.50% |
| Return on Assets | -18.80% |
| Revenue/Share (TTM) | $3.68 |
| Book Value | $5.54 |
| Price-to-Book | 1.32 |
| Price-to-Sales (TTM) | 1.71 |
| EV/Revenue | 0.835 |
| EV/EBITDA | 0.76 |
| Quarterly Earnings Growth (YoY) | -95.90% |
| Quarterly Revenue Growth (YoY) | 3.40% |
| Shares Outstanding | $60.14M |
| Float | $53.82M |
| % Insiders | 6.12% |
| % Institutions | 78.66% |
Historical Volatility
HV 10-Day
29.76%
HV 20-Day
67.13%
HV 30-Day
57.96%
HV 60-Day
72.52%
HV Rank
46.0%
Volatility is currently contracting
Analyst Ratings
Consensus ($14.90 target)
4
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026